Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Lineage Cell Therapeutics, Inc. | Director | Common Shares | 299K | $169K | $0.57 | Nov 22, 2024 | Direct |
Lineage Cell Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 75K | Jul 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LCTX | Lineage Cell Therapeutics, Inc. | Nov 22, 2024 | 1 | $22.6K | 4 | Nov 25, 2024 | Director |
LCTX | Lineage Cell Therapeutics, Inc. | Jul 1, 2024 | 1 | $0 | 4 | Jul 3, 2024 | Director |
LCTX | Lineage Cell Therapeutics, Inc. | Jul 1, 2023 | 1 | $0 | 4 | Jul 3, 2023 | Director |
LCTX | Lineage Cell Therapeutics, Inc. | Jul 1, 2022 | 1 | $0 | 4 | Jul 6, 2022 | Director |
LCTX | Lineage Cell Therapeutics, Inc. | Mar 24, 2022 | 1 | $9.8K | 4 | Mar 25, 2022 | Director |
LCTX | Lineage Cell Therapeutics, Inc. | Jul 1, 2021 | 1 | $0 | 4 | Jul 1, 2021 | Director |
LCTX | Lineage Cell Therapeutics, Inc. | Jun 18, 2021 | 2 | $54.4K | 4 | Jun 21, 2021 | Director |